RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,540,807 | +12.1% | 92,708 | +26.1% | 0.00% | – |
Q2 2023 | $1,374,543 | -46.2% | 73,505 | -47.2% | 0.00% | – |
Q1 2023 | $2,554,981 | -9.9% | 139,236 | -2.8% | 0.00% | – |
Q4 2022 | $2,835,103 | +138.8% | 143,187 | +190.2% | 0.00% | – |
Q3 2022 | $1,187,000 | +623.8% | 49,338 | +449.1% | 0.00% | – |
Q2 2022 | $164,000 | -79.3% | 8,986 | -75.1% | 0.00% | – |
Q1 2022 | $794,000 | -73.7% | 36,123 | -56.1% | 0.00% | – |
Q4 2021 | $3,020,000 | +967.1% | 82,233 | +800.6% | 0.00% | – |
Q3 2021 | $283,000 | +13.2% | 9,131 | +15.7% | 0.00% | – |
Q2 2021 | $250,000 | +45.3% | 7,895 | +1.7% | 0.00% | – |
Q1 2021 | $172,000 | +95.5% | 7,760 | +73.5% | 0.00% | – |
Q4 2020 | $88,000 | -26.7% | 4,473 | +20.3% | 0.00% | – |
Q3 2020 | $120,000 | -81.9% | 3,717 | -83.7% | 0.00% | – |
Q2 2020 | $663,000 | +5425.0% | 22,870 | +3870.5% | 0.00% | – |
Q1 2020 | $12,000 | +71.4% | 576 | +142.0% | 0.00% | – |
Q4 2019 | $7,000 | – | 238 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |